1. Radiation Modifiers
   Deborah E. Citrin, 2019, Hematology/Oncology Clinics of North America CrossRef
2. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer
   JIA GU et al, 2014, International Journal of Oncology CrossRef
3. Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance
   Katrien Konings et al, 2020, Frontiers in Oncology CrossRef
4. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma
   Ravi S. Narayan et al, 2018, Molecular Cancer Therapeutics CrossRef
5. MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule
   Felix Grabenbauer et al, 2018, Oncotarget CrossRef
6. Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo
   M. Houweling et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
7. Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment
   Ryan Chan et al, 2016, Radiation Research CrossRef
8. Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer
   Miljana Tanić et al, 2018, Radiation Oncology CrossRef
9. Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non–Small Cell Lung Cancer
   Ashish Sharma et al, 2016, Clinical Cancer Research CrossRef
10. Translation of Targeted Radiation Sensitizers into Clinical Trials
    Zachery R. Reichert et al, 2016, Seminars in Radiation Oncology CrossRef
11. Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization
    Sebastian Kuger et al, 2015, Radiation Oncology CrossRef
12. Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma
    Yaoqi Ge et al, 2018, PLOS ONE CrossRef
13. MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer
    Lanlan Li et al, 2013, FEBS Letters CrossRef